Sol-Gel Technologies Ltd. NCM · SLGL

Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering

GlobeNewswire Inc. · 120d ago

Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

GlobeNewswire Inc. · 315d ago

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

GlobeNewswire Inc. · 341d ago

Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates

Zacks Investment Research · 793d ago

Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel

GlobeNewswire Inc. · 797d ago

Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates

Zacks Investment Research · 798d ago

Sharecare, Inc. (SHCR) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research · 803d ago

Bausch Health (BHC) Q1 Earnings and Revenues Miss Estimates

Zacks Investment Research · 811d ago

Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream

GlobeNewswire Inc. · 842d ago

Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments

GlobeNewswire Inc. · 861d ago

Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates

Zacks Investment Research · 867d ago

Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates

Zacks Investment Research · 875d ago

Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610

GlobeNewswire Inc. · 967d ago

Zacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies

Zacks Investment Research · 995d ago

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

Zacks Investment Research · 996d ago

Stocks That Hit 52-Week Lows On Thursday

Benzinga · 1021d ago

Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates

Zacks Investment Research · 1078d ago

Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada

GlobeNewswire Inc. · 1142d ago

Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga · 1218d ago

Sol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference

GlobeNewswire Inc. · 1220d ago

Homology Medicines (FIXX) Reports Q4 Loss, Misses Revenue Estimates

Zacks Investment Research · 1230d ago

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Beat Estimates

Zacks Investment Research · 1239d ago

Sol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offerings

GlobeNewswire Inc. · 1272d ago